ROR1 signaling also influences MAPK/ERK pathway and promotes survival, while activation of NF-κB pathway contributes to therapy resistance Moreover, ROR1 signaling can indirectly modulate the JAK/STAT pathway, further enhancing tumor cells survival and resistance to therapy [12–15]. This evidence concerns the gene ROR1 and neoplasm.